BioHarvest Sciences Inc.

Equities

BHSC

CA09076J1084

Food Processing

Market Closed - Canadian Securities Exchange 02:00:13 2024-04-26 pm EDT 5-day change 1st Jan Change
0.26 CAD +1.96% Intraday chart for BioHarvest Sciences Inc. 0.00% +20.93%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
BioHarvest Sciences Inc. Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity CI
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules MT
BioHarvest Sciences Inc. Announces Launch of New Contract Development and Manufacturing Organization Business Unit CI
BioHarvest Sciences Inc. Signs First Contracts with Two Industrial Customers to Develop Complex Molecules Via Its Newly Launched Botanical Synthesis CDMO Business Unit CI
BioHarvest Sciences Inc. announced that it has received CAD 13.622872 million in funding CI
Bioharvest Sciences Inc. Announces Major Product Launch of Vinia-Based Functional Coffee Products CI
BioHarvest Sciences Inc. Provides Revenue Guidance for the Fourth Quarter 2023 CI
Bioharvest Sciences Inc. Revises Revenue Guidance for the Year 2023 CI
BioHarvest Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
BioHarvest Sciences Inc. announced that it expects to receive CAD 12 million in funding CI
BioHarvest Sciences Inc. Receives Canadian Product License from Health Canada's Natural and Non-Prescription Health Products Directorate CI
BioHarvest Sciences Inc. Provides Revenue Guidance for the Third Quarter of 2023 CI
BioHarvest Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
BioHarvest Sciences Up After Reporting Closing of Private Placement of Convertible Notes MT
BioHarvest Sciences Inc. announced that it has received CAD 4.642076 million in funding CI
BioHarvest Sciences Inc. announced that it expects to receive CAD 4.625103 million in funding CI
BioHarvest Sciences Inc. Announces Appointment of John Paul Sangiovanni as Medical and Scientific Advisory Board CI
Bioharvest Sciences Inc. Reiterated Sales Guidance for the year 2023 CI
BioHarvest Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
BioHarvest Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
BioHarvest Sciences Inc. Auditor Raises 'Going Concern' Doubt CI
Bioharvest Sciences Inc. Hires Dr. Ilana Belzer as Chief Operating Officer CI
BioHarvest Sciences Inc. announced that it has received CAD 8 million in funding CI
BioHarvest Sciences Inc. Announces Clinical Study in Patients with Multiple Sclerosis-Related Optic Neuritis CI
Bioharvest Sciences Inc. Appoints George Garibaldi to its Scientific Board of Advisors CI
Chart BioHarvest Sciences Inc.
More charts
BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals: as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Company offers a polyphenol/antioxidant superfruit product called VINIA, which is a red grape powder that supplies the benefits of red wine consumption but without the sugar, calories and alcohol found in wine.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. BHSC Stock
  4. News BioHarvest Sciences Inc.
  5. BioHarvest Sciences Up After Reporting Closing of Private Placement of Convertible Notes